Pyrazinecarboxylic acid amide
Pyrazinecarboxylic acid amide Brand names, Pyrazinecarboxylic acid amide Analogs
- Aldinamid
- Aldinamide
- Braccopiral
- Corsazinmid
- Dipimide
- Eprazin
- Farmizina
- Isopas
- Lynamide
- Novamid
- Pyrazinamdie
- PZA
- Pezetamid
- Piraldina
- Pirazimida
- Pirazinamid
- Pirilene
- Prazina
- Pyrafat
- Pyramide
- Pyrazide
- Pyrazinamide BP 2000
- Pyrazine carboxylamide
- Pyrazineamide
- Pyrazinecarboxamide
- Pyrazinecarboxylic acid amide
- Pyrazinoic acid amide
- Rifater
- Rozide
- Tebrazid
- Tebrazio
- Unipyranamide
- Zinamide
- Zinastat
- pms-Pyrazinamide
Pyrazinecarboxylic acid amide Brand Names Mixture
- No information avaliable
Pyrazinecarboxylic acid amide Chemical_Formula
C43H51N3O11
Pyrazinecarboxylic acid amide RX_link
http://www.rxlist.com/cgi/generic/xifaxan.htm
Pyrazinecarboxylic acid amide fda sheet
Pyrazinecarboxylic acid amide msds (material safety sheet)
Pyrazinecarboxylic acid amide Synthesis Reference
No information avaliable
Pyrazinecarboxylic acid amide Molecular Weight
785.879 g/mol
Pyrazinecarboxylic acid amide Melting Point
No information avaliable
Pyrazinecarboxylic acid amide H2O Solubility
No information avaliable
Pyrazinecarboxylic acid amide State
No information avaliable
Pyrazinecarboxylic acid amide LogP
4.161
Pyrazinecarboxylic acid amide Dosage Forms
No information avaliable
Pyrazinecarboxylic acid amide Indication
For the treatment of patients (>=12 years of age) with travelers' diarrhea caused by noninvasive strains of Escherichia coli.
Pyrazinecarboxylic acid amide Pharmacology
Rifaximin is a structural analog of rifampin and non-systemic, gastrointestinal site-specific antibiotic. Rifaximin acts by inhibiting bacterial ribonucleic acid (RNA) synthesis. While an increase in pulmonary hydrogen excretion is evident in diverticular disease, the therapeutic effect of rifaximin does not appear to be due to a persistent correction of this alteration and the drug appears to cause no significant imbalance in the intestinal ecosystem.
Pyrazinecarboxylic acid amide Absorption
Low absorption in both the fasting state and when administered within 30 minutes of a high-fat breakfast.
Pyrazinecarboxylic acid amide side effects and Toxicity
LD50 > 2 g/kg (orally, in rats)
Pyrazinecarboxylic acid amide Patient Information
No information avaliable
Pyrazinecarboxylic acid amide Organisms Affected
Enteric bacteria and eubacteria
